Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Sakai

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of GedatolisibShigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.
Nature|November 25, 2021
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancerHiroki Izumi, Shingo Matsumoto, Jie Liu, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of GedatolisibShigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.
Nature|November 25, 2021
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancerHiroki Izumi, Shingo Matsumoto, Jie Liu, et al.
Pageof 9